Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI
Open access

Comparison of hiPSC-derived hepatic organoids and liver-on-a-chip systems reveal microenvironment-driven maturation

Isabel Tamargo-Rubio T. Krempel Victoria Palasantzas Bella Green G. Weijer R. Moerkens C. V. D. Van Der Woude S. V. van IJzendoorn D. Touw J. Hoogerland S. Withoff Jing-Yuan Fu
Jul 2026 · bioRxiv · 0 citations · 58 references
Biology

TL;DR

A cryopreservable and scalable workflow is developed to generate hiPSC-derived hepatic organoids that can be directly matured to either static HLOs or LoC systems, enabling matched comparison of both platforms and establishing a robust hiPSC-derived LoC platform.

DOI Semantic Scholar
Read PDF

Similar papers

Open access Aug 2026

A human iPSC-derived kidney–liver organ-on-a-chip platform for modeling inter-organ crosstalk

The liver and kidneys are essential for drug metabolism and clearance and are highly sensitive to toxicity. Most in vitro models assess these organs in isolation, limiting the study of inter-organ interactions. Here, an induced pluripotent stem cell (iPSC)-derived kidney–liver organ-on-a-chip model was developed that c...

Lenya de Brouwer, Victoria Pozo Garcia, M. Kiamehr et al. · 0 citations
Open access Aug 2026

Mesenchymal stem cell-derived liver-on-a-chip reconstitutes human liver structure and function.

An in vitro model of human liver with functional integrity would advance liver research and enable personalized therapeutics. A microfluidic liver-on-a-chip can generate a functional hepatobiliary network using human liver cells and recapitulate blood circulation and bile excretion. However, many current microfluidic l...

Anastasia Brooks, Haotian Yang, D. Barkauskas et al. · 0 citations
Open access Aug 2026

Behaviour of iPSC-Derived and Donor-Derived Hepatic Stellate Cells in Organoid Cultures Is Highly Variable and Contributes to Fibrotic Outcome

It is suggested that HSC heterogeneity, whether iPSC-derived or donor-derived, is an important factor in fibrotic output and response variability in human liver organoid models and should be considered in model design, interpretation and comparison between studies.

Yu-Wei Yang, Mina Kazemzadeh Dastjerd, Ayla J. Smout et al. · 0 citations
Review Open access Sep 2026

Human Liver Organoid Platforms for MASH Drug Discovery: Evaluating Immunometabolic Fidelity, Pharmacological Predictivity, and Translational Readiness

Overall, liver organoids are best viewed as fit-for-purpose tools for mechanistic studies, target validation and early candidate evaluation, with future progress requiring improved standardisation, patient-tissue benchmarking and clinically relevant validation.

Bo-Lun Pan · 0 citations
Open access Aug 2026

Integrated analyses of in vivo mouse models and liver organoids reveal MFG-E8-mediated protection against hepatocyte injury.

Milk Fat Globule-EGF Factor 8 (MFG-E8) is a multifunctional glycoprotein implicated in tissue homeostasis and repair. While its roles in intestinal and pancreatic injury are well established, its function in hepatic regeneration remains poorly defined. In this study, we investigated MFG-E8 expression and activity using...

H. Bu, Q. Jiang, Hua Geng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.